Portable optical microchip performs accurate foot and mouth disease detection

June 21, 2011
Stratophase has wrapped up its Portable Direct Immunoassay Diagnosis Devices for Animals and Humans project, which assessed the feasibility of using a self-contained, portable detection unit that uses proprietary optical microchip technology to accurately identify the presence of foot and mouth disease.

Stratophase (Romsey, England) has wrapped up its Portable Direct Immunoassay Diagnosis Devices for Animals and Humans (PDIDDAH) project, which assessed the feasibility of using a self-contained, portable detection unit that uses proprietary optical microchip technology to accurately identify the presence of foot and mouth disease (FMD). The device could—if further developed—allow veterinary professionals, inspectors and farmers to make rapid, informed decisions at the site of infection during disease outbreaks, avoiding the need to cull of healthy livestock.

Stratophase's transportable FMD detection unit, which uses the company's proprietary optical microchip technology, measures changes in refractive index (RI) at the surface of an optical chip. During analysis, the sample is mixed with a liquid and pumped across the chip surface, where any FMD viral particles present bind to specific receptor molecules, altering the local RI and leading to positive detection. The chips themselves are incorporated into low-cost, disposable cartridges, which are inserted into the detection unit during testing.

Stratophase's transportable foot and mouth disease (FMD) detection unit uses proprietary optical microchip technology to analyze samples, measuring changes in the refractive index (RI) to detect any FMD viral particles that may be present.

In addition to veterinary diagnostics, Stratophase's optical microchips can be configured to detect a whole range of biological agents, making them ideal for on-site testing in environments as diverse as battlefields, hospitals and farms, according to Richard Williams, Stratophase’s CEO. The company expects to commercialize its portable detection solution for veterinary diagnostics in the future through collaboration with strategic partners already active in the field, he says.

The £1 million project, co-funded by the UK government-sponsored Technology Strategy Board (Swindon, England), was performed in collaboration with the Institute of Biotechnology (University of Cambridge; Cambridge, England), Bristol Industrial and Research Associates Limited (Bristol, England) and the Chelsea Technologies Group (Surrey, England).

-----

Posted by Lee Mather

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Follow OptoIQ on your iPhone; download the free app here.

Subscribe now to BioOptics World magazine; it's free!

Sponsored Recommendations

Next generation tunable infrared lasers

Nov. 28, 2023
Discussion of more powerful and stable quantum cascade tunable infrared lasers, applications, and test results.

What AI demands mean for data centers

Nov. 28, 2023
The 2023 Photonics-Enabled Cloud Computing Summit assembled by Optica took an aggressive approach to calling out the limitations of today’s current technologies.

SLP feature for lighting control available on cameras offering

Nov. 28, 2023
A proprietary structured light projector (SLP) feature is now available on the company’s camera series, including the ace 2, boost R, ace U, and ace L.

Chroma Customer Spotlight - Dr. David Warshaw, About his Lab

Nov. 27, 2023
David Warshaw, Professor and Chair of Molecular Physiology and Biophysics at the University of Vermont (UVM), walks us through his lab. Learn about his lab’s work with the protein...

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!